NCT07678983Active, not recruiting
Whole-Body Vibration in Parkinson Disease
Effects of Whole-Body Vibration at Different Frequencies on Balance, Gait, Cognitive Functions, and Dual-Task Performance in Patients With Parkinson's Disease: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
The aim of this study is to evaluate the effects of different frequencies of Whole Body Vibration (WBV) application on balance, gait, cognitive functions, and dual-task performance in patients with Parkinson's disease. Study Hypotheses: H0.1 - There is no effect of different frequencies of WBV application on balance performance in patients with Parkinson's disease. H1.1 - There is an effect of different frequencies of WBV application on balance performance in patients with Parkinson's disease. H0.2 - There is no effect of different frequencies of WBV application on gait performance in patients with Parkinson's disease. H1.2 - There is an effect of different frequencies of WBV application on gait performance in patients with Parkinson's disease. H0.3 - There is no effect of different frequencies of WBV application on cognitive functions in patients with Parkinson's disease. H1.3 - There is an effect of different frequencies of WBV application on cognitive functions in patients with Parkinson's disease. H0.4 - There is no effect of different frequencies of WBV application on dual-task performance in patients with Parkinson's disease. H1.4 - There is an effect of different frequencies of WBV application on dual-task performance in patients with Parkinson's disease. H0.5 - There is no effect of different frequencies of WBV application on reaction time in patients with Parkinson's disease. H1.5 - There is an effect of different frequencies of WBV application on reaction time in patients with Parkinson's disease. H0.6 - There is no significant difference between medium-frequency and low-frequency WBV in terms of balance performance in patients with Parkinson's disease. H1.6 - There is a significant difference between medium-frequency and low-frequency WBV in terms of balance performance in patients with Parkinson's disease. H0.7 - There is no significant difference between medium-frequency and low-frequency WBV in terms of gait performance in patients with Parkinson's disease. H1.7 - There is a significant difference between medium-frequency and low-frequency WBV in terms of gait performance in patients with Parkinson's disease. H0.8 - There is no significant difference between medium-frequency and low-frequency WBV in terms of cognitive functions in patients with Parkinson's disease. H1.8 - There is a significant difference between medium-frequency and low-frequency WBV in terms of cognitive functions in patients with Parkinson's disease. H0.9 - There is no significant difference between medium-frequency and low-frequency WBV in terms of dual-task performance in patients with Parkinson's disease. H1.9 - There is a significant difference between medium-frequency and low-frequency WBV in terms of dual-task performance in patients with Parkinson's disease. H0.10 - There is no significant difference between medium-frequency and low-frequency WBV in terms of reaction time in patients with Parkinson's disease. H1.10 - There is a significant difference between medium-frequency and low-frequency WBV in terms of reaction time in patients with Parkinson's disease.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 25 Jun 2026
- Start date
- 20 Jan 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- Izmir Bakircay University
- Diseases
- Parkinson disease
- NCT number
- NCT07678983
What you commit to
- Study type: Interventional
- Participants enrolled: 66
- From 20 Jan 2026 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Changes in medication or medical status during the study that may affect participation or performance.
Other illness
- Advanced stage Parkinson's disease (Hoehn and Yahr stage \>3) or presence of severe motor complications.
- History of surgical interventions or other neurological/vestibular disorders that may affect balance and gait (E.G., stroke, epilepsy, peripheral neuropathy).
- Presence of severe cardiovascular or respiratory conditions that may affect stability (E.G., heart failure, uncontrolled hypertension, advanced COPD).
- Conditions contraindicating whole-body vibration (WBV) application (E.G., severe osteoporosis, active thrombosis).
- Psychiatric disorders or major depression that may interfere with treatment participation.
- Development of health problems during the intervention that prevent completion of the study (E.G., unexpected acute illness or temporary medical condition).
Other
- Significant communication or language impairments affecting participation.
- Withdrawal Criteria
- Voluntary withdrawal from the study.
- Non-adherence to the protocol (attendance rate below 80% of sessions).
Who the study is looking for
- Individuals aged 30-80 years with a clinical diagnosis of Parkinson's disease. Hoehn and Yahr stages 1-3.
- Stable medical treatment (no changes in medication for the past 4 weeks).
- Willingness to participate and provision of written informed consent.
- Score of 24 or higher on the Standardized Mini Mental State Examination (SMMSE).
Age in the registry: 30 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Izmir Bakircay University Cigli Training and Research Hospital Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.